Related references
Note: Only part of the references are listed.Optical Deconstruction of Parkinsonian Neural Circuitry
Viviana Gradinaru et al.
SCIENCE (2009)
Molecular mechanisms of L-DOPA-induced dyskinesia
Peter Jenner
NATURE REVIEWS NEUROSCIENCE (2008)
Striatal Plasticity and Basal Ganglia Circuit Function
Anatol C. Kreitzer et al.
NEURON (2008)
Automated three-dimensional analysis of histological and autoradiographic rat brain sections: application to an activation study
Albertine Dubois et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates
M. Kuoppamaki et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC
Krystof S. Bankiewicz et al.
MOLECULAR THERAPY (2006)
Post-versus presynaptic plasticity in L-DOPA-induced dyskinesia
M. Angela Cenci et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
C. Warren Olanow et al.
LANCET NEUROLOGY (2006)
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease
R Cools
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2006)
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors
T Carlsson et al.
BRAIN (2005)
Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease
M Sun et al.
HUMAN GENE THERAPY (2004)
Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients
ML Welter et al.
ARCHIVES OF NEUROLOGY (2004)
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
CW Olanow et al.
ANNALS OF NEUROLOGY (2003)
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
E Bézard et al.
NATURE MEDICINE (2003)
Treatment interventions for Parkinson's disease: an evidence based assessment
O Rascol et al.
LANCET (2002)
New methods to titrate EIAV-based lentiviral vectors
E Martin-Rendon et al.
MOLECULAR THERAPY (2002)
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes
SI Muramatsu et al.
HUMAN GENE THERAPY (2002)
Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery
ND Mazarakis et al.
HUMAN MOLECULAR GENETICS (2001)
Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates:: Comparison with 6-[18F] Fluoro-L-Dopa
T Poyot et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
CR Freed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey
T Boraud et al.
BRAIN (2001)
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
JH Kordower et al.
SCIENCE (2000)
Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease
JA Saint-Cyr et al.
BRAIN (2000)
Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease
Y Shen et al.
HUMAN GENE THERAPY (2000)
Hallucinations in Parkinson's disease -: Prevalence, phenomenology and risk factors
G Fénelon et al.
BRAIN (2000)
Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey
C Imbert et al.
JOURNAL OF NEUROSCIENCE METHODS (2000)